Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.675 USD | -2.62% | +10.93% | +90.34% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+90.34% | 216M | |
+20.08% | 46.81B | |
-0.82% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.64% | 26.06B | |
-19.68% | 19.13B | |
+32.71% | 12.39B | |
+0.19% | 12.08B | |
-0.52% | 11.96B |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Atossa Therapeutics : to Move Forward With Phase 2 Trial of Oral Endoxifen for Mammographic Breast Density in Sweden